Cargando…

Efficacy and Safety of 0.1% Cyclosporine versus 2% Cyclosporine in the Treatment of Severe Vernal Keratoconjunctivitis in Children

INTRODUCTION: Vernal keratoconjunctivitis (VKC) is an inflammatory condition in children that can cause severe eye complications. Treatment is based on corticosteroid therapy during flare-ups, then antihistamines and cyclosporine in calmer periods. The dosage and posology of cyclosporine are subject...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourcier, Tristan, Dory, Anne, Dormegny, Lea, Alcazar, Joffrey, Gaucher, David, Sauer, Arnaud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596278/ https://www.ncbi.nlm.nih.gov/pubmed/36304991 http://dx.doi.org/10.2147/OPTH.S370414

Ejemplares similares

Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis
por: Gokhale, Nikhil S, et al.
Publicado: (2012)

Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children
por: Chatterjee, Arkendu, et al.
Publicado: (2019)

Eye drop emulsion containing 0.1% cyclosporin (1 mg/mL) for the treatment of severe vernal keratoconjunctivitis: an evidence-based review and place in therapy
por: Nebbioso, Marcella, et al.
Publicado: (2019)

Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus ointment in children with vernal keratoconjunctivitis
por: Saha, Bhawesh Chandra, et al.
Publicado: (2023)

Tear Ferning Test and Pathological Effects on Ocular Surface before and after Topical Cyclosporine in Vernal Keratoconjunctivitis Patients
por: Nebbioso, Marcella, et al.
Publicado: (2018)

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials
por: Leonardi, Andrea, et al.
Publicado: (2022)

Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen
por: Chan, Yuan-Hsi, et al.
Publicado: (2023)

Vernal keratoconjunctivitis
por: Addis, Hampton, et al.
Publicado: (2018)

Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach
por: Ghiglioni, Daniele Giovanni, et al.
Publicado: (2020)

Resident Skills Assessment in Corneal Suturing: A Comprehensive Review of Currently Proposed Educational Programs and Evaluation Tools
por: Dormegny, Lea, et al.
Publicado: (2021)

Management of Vernal Keratoconjunctivitis
por: Leonardi, Andrea
Publicado: (2013)

Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis
por: Okumus, Seydi, et al.
Publicado: (2012)

Clinical Outcomes of Topical 0.1% Ciclosporin Cationic Emulsion Used on Label in Children with Vernal Keratoconjunctivitis
por: Giannaccare, Giuseppe, et al.
Publicado: (2023)

Combination of 0.05% Azelastine and 0.1% Tacrolimus Eye Drops in Children With Vernal Keratoconjunctivitis: A Prospective Study
por: Chen, Minjie, et al.
Publicado: (2021)

Multiple metrics assessment method for a reliable evaluation of corneal suturing skills
por: Dormegny, Lea, et al.
Publicado: (2023)

Vitiligo in association with vernal keratoconjunctivitis
por: Kumar, Sunil, et al.
Publicado: (2016)

Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis
por: Shoughy, Samir S, et al.
Publicado: (2016)

A Prospective Study of Cyclosporine A 0.1% Combined with Loteprednol 0.2% vs Cyclosporine A 0.05% Alone in the Treatment of Dry Eye
por: Hovanesian, John, et al.
Publicado: (2023)

Comparative analysis of 0.1% cyclosporin A cationic emulsion and 0.05% cyclosporin A emulsion in murine dry eye cases with different severities
por: Jin, Rujun, et al.
Publicado: (2021)

Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis
por: Al-Amri, Abdulrahman M., et al.
Publicado: (2016)

Role of ocular cytology in vernal keratoconjunctivitis
por: Bruschi, Gaia, et al.
Publicado: (2019)

Vernal Keratoconjunctivitis: A Systematic Review
por: Bruschi, Gaia, et al.
Publicado: (2023)

Effectiveness of Topical Cyclosporin-A 0.1% Compared to Combined Topical Cyclosporin-A 0.1% with Topical Sodium Hyaluronate on Interleukin-6 Levels in the Tears of Patients with Dry Eye Disease
por: Priani, Desti, et al.
Publicado: (2023)

Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates
por: Bayraktutar, Betül N., et al.
Publicado: (2016)

To evaluate the efficacy and safety of olopatadine 0.1% ophthalmic solution and bepotastine 1.5% ophthalmic solution in patients with vernal keratoconjunctivitis in a tertiary care hospital
por: Sruthi, Vadlakonda, et al.
Publicado: (2020)

Diagnosis, Management, and Treatment of Vernal Keratoconjunctivitis in Asia: Recommendations From the Management of Vernal Keratoconjunctivitis in Asia Expert Working Group
por: Mehta, Jodhbir S., et al.
Publicado: (2022)

One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease
por: Baudouin, Christophe, et al.
Publicado: (2017)

Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion
por: Matossian, Cynthia, et al.
Publicado: (2021)

Safety and Efficacy of Corneal Cross-linking in Pediatric Patients with Keratoconus and Vernal Keratoconjunctivitis
por: Alrobaian, Malek, et al.
Publicado: (2019)

Therapeutic Effect of 0.03% Tacrolimus Ointment for Ocular Graft versus Host Disease and Vernal Keratoconjunctivitis
por: Ryu, Eun Hye, et al.
Publicado: (2012)

Management of vernal keratoconjunctivitis in children in Saudi Arabia
por: AlHarkan, Dora Hamad
Publicado: (2020)

Corneal and lens densitometry in patients with vernal keratoconjunctivitis
por: Yılmaz, Yusuf Cem, et al.
Publicado: (2021)

Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives
por: Chigbu, DeGaulle I., et al.
Publicado: (2021)

Understanding Vernal Keratoconjunctivitis: Beyond Allergic Mechanisms
por: Sacchetti, Marta, et al.
Publicado: (2021)

Vernal keratoconjunctivitis: state of art and update on treatment
por: Brindisi”, Giulia, et al.
Publicado: (2021)

Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis
por: Al-Amri, Abdulrahman Mohammed, et al.
Publicado: (2017)

A Review of Topical Cyclosporine A Formulations—A Disease-Modifying Agent for Keratoconjunctivitis Sicca
por: Jerkins, Gary W, et al.
Publicado: (2020)

A Randomized Study of the Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in Treatment of Moderate to Severe Dry Eye
por: Baudouin, Christophe, et al.
Publicado: (2017)

Safety and efficacy of topical tacrolimus 0.03% in the management of vernal keratoconjunctivitis: a non-randomized controlled clinical trial
por: Eltagoury, Mahmoud, et al.
Publicado: (2022)

Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye
por: Park, Chang Hyun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eccp0evbsstt0e01o19dju4e4f